Related Experiment Video
Updated: May 21, 2026
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Measurements of β-arrestin recruitment to activated seven transmembrane receptors using enzyme complementation
Daniel L Bassoni1, William J Raab, Philip L Achacoso
1DiscoveRx Corporation, Fremont, CA, USA.
Abstract:
The recruitment of arrestins to activated 7TMRs results in the activation of alternative signaling pathways, quenching of G-protein activation, and coupling to clathrin-mediated endocytosis. The nearly ubiquitous involvement of arrestin in 7TMR signaling has spurred the development of several methods for monitoring this interaction in mammalian cells. Nonetheless, few maintain the reproducibility and precision necessary for drug discovery applications. Enzyme fragment complementation technology (EFC) is an emerging protein-protein interaction technology based on the forced complementation of a split enzyme that has proven to be highly effective in monitoring the formation of GPCR-arrestin complexes. In these systems, the target proteins are fused to two fragments of an enzyme that show little or no spontaneous complementation. Interaction of the two proteins forces the complementation of the enzyme, resulting in an enzymatic measure of the protein interaction. This chapter discusses the utility and methods involved in using the PathHunter β-galactosidase complementation system to monitor arrestin recruitment and the advantages of exploiting this pathway in the characterization of 7TMR function.
Insights
Monitoring arrestin recruitment to 7 transmembrane receptors (7TMRs) is crucial for drug discovery. Enzyme fragment complementation technology (EFC) offers a precise method to study these interactions in mammalian cells.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Arrestin recruitment to activated 7 transmembrane receptors (7TMRs) modulates signaling and endocytosis.
- Accurate monitoring of GPCR-arrestin interactions is vital for drug discovery.
- Existing methods often lack the reproducibility and precision required for pharmaceutical applications.
Purpose of the Study:
- To discuss the utility and methods of the PathHunter β-galactosidase complementation system.
- To highlight the advantages of this system for characterizing 7TMR function.
- To demonstrate its application in monitoring arrestin recruitment.
Main Methods:
- Utilizing Enzyme Fragment Complementation (EFC) technology.
- Employing a split β-galactosidase enzyme system for protein-protein interaction detection.
- Fusing target proteins to enzyme fragments that complement upon interaction.
Main Results:
- EFC effectively monitors the formation of GPCR-arrestin complexes.
- The PathHunter system provides an enzymatic readout of protein interactions.
- This method demonstrates high effectiveness in studying arrestin recruitment.
Conclusions:
- The PathHunter β-galactosidase complementation system is a valuable tool for monitoring arrestin recruitment.
- EFC offers a reproducible and precise method for GPCR-arrestin interaction studies.
- This technology enhances the characterization of 7TMR signaling pathways for drug discovery.
